for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Allogene Therapeutics Q1 Loss Per Share $0.50

May 6 (Reuters) - Allogene Therapeutics Inc:

* ALLOGENE THERAPEUTICS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS

* Q1 LOSS PER SHARE $0.50

* Q1 EARNINGS PER SHARE ESTIMATE $-0.58 -- REFINITIV IBES DATA

* AS OF MARCH 31, 2020, ALLOGENE HAD $553.0 MILLION IN CASH, CASH EQUIVALENTS, AND INVESTMENTS

* CONTINUES TO EXPECT FULL YEAR GAAP NET LOSSES TO BE BETWEEN $260 MILLION AND $280 MILLION Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up